Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $59.84 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $43.64 | 3 | $0 (2023) |
| Madrigal Pharmaceuticals | $16.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.20 | 1 | Madrigal Pharmaceuticals ($16.20) |
| 2023 | $43.64 | 3 | Celgene Corporation ($43.64) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: LIVER DISEASE | ||||||
| 08/11/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Neuroscience | ||||||
| 07/28/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Neuroscience | ||||||
| 01/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 417 | 547 | $360,935 | $59,058 |
| 2022 | 5 | 198 | 270 | $173,180 | $28,547 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 99 | 162 | $58,655 | $15,949 | 27.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 88 | 88 | $54,520 | $12,706 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 108 | $40,280 | $10,721 | 26.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 27 | $46,665 | $5,624 | 12.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 37 | 42 | $66,190 | $3,113 | 4.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 22 | $10,890 | $3,037 | 27.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 40 | 45 | $62,300 | $2,885 | 4.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $11,570 | $2,479 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $4,465 | $1,306 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,400 | $1,239 | 22.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 69 | $45,440 | $11,388 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 130 | $44,200 | $11,089 | 25.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 32 | $44,800 | $2,320 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 19 | $6,840 | $2,092 | 30.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $31,900 | $1,657 | 5.2% |
About Dr. Evan Orosz, DO
Dr. Evan Orosz, DO is a Gastroenterology healthcare provider based in Neptune, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2015. The National Provider Identifier (NPI) number assigned to this provider is 1487049797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Orosz, DO has received a total of $59.84 in payments from pharmaceutical and medical device companies, with $16.20 received in 2024. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($59.84).
As a Medicare-enrolled provider, Orosz has provided services to 615 Medicare beneficiaries, totaling 817 services with total Medicare billing of $87,605. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Neptune, NJ
- Active Since 04/02/2015
- Last Updated 02/04/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487049797
Products in Payments
- ZEPOSIA (Drug) $43.64
- RESMETIROM (Drug) $16.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Neptune
Haroon Shahid, M.d, M.D
Gastroenterology — Payments: $31,178
Dr. Sabyasachi Mohapatra, M.d, M.D
Gastroenterology — Payments: $2,629
Ammar Qureshi, Md, MD
Gastroenterology — Payments: $2,045
Douglas Weinstein, Md, MD
Gastroenterology — Payments: $1,415
Nicolas Patel, M.d, M.D
Gastroenterology — Payments: $1,043
Maulik Shah, Do, DO
Gastroenterology — Payments: $959.45